ACTRN12618000195257已完成1 期
A Single-Center, Randomized, Double-Blind, Placebo Controlled, Multiple-Dose, Dose Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045 Administered Orally to Normal, Healthy Volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
撤回
1 期
A Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral AD-6626 in Normal, Healthy VolunteersThis study is for healthy volunteers. The intended use of the investigational product is the treatment of Fanconi AnemiaBlood - Haematological diseasesHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersACTRN12615000601538Aldea Pharmaceuticals24
招募中
1 期
A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of KDF-07002 in Healthy, Adult VolunteersThis trial is to assess safety and tolerability of KDF-07002 in healthy adult males and dose not focus on any particular health condition or problemOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12609000086268ucleus Network, Ltd.54
已完成
1 期
A Single-Center, Randomized, Double-Blind, Placebo Controlled Study of the Safety, Tolerability and Pharmacokinetics of Various Concentrations of Topical SM04554 Solution in Male Subjects with Androgenetic Alopecia.Skin - Dermatological conditionsAndrogenetic AlopeciaACTRN12613000974707Samumed LLC30
未知
1 期
Multiple-Dose Phase 1 Study of SCO-792JPRN-jRCT2080223770SCOHIA PHARMA, Inc.36
未知
1 期
Single-Dose Phase 1 Study of TAK-792Healthy Adult Male ParticipantsJPRN-jRCT2080222845TAKEDA PHARMACEUTICAL COMPANY LTD.103